Background. Various strategies for the prevention of contrast-induced nephropathy (CN) have been studied, with conflicting results. Adenosine may play an important role in the pathogenesis of CN. This study prospectively assessed the role of oral theophylline in the prevention of CN.
Introduction
Nephrotoxicity due to the administration of radiocontrast agents is a common and preventable cause of acute renal failure (ARF). Contrast-induced nephropathy (CN) is the third leading cause of ARF in hospitalized patients [1] . The incidence of CN, which varies from 0 to 23% in patients undergoing cardiac catheterization and angiography, depends on the definition of CN used and the risk profile of the patient population included in the study [2] . Usually, CN is defined as a rise in serum creatinine of P25%, or P50% of the baseline value, and appears to be the result of a synergistic combination of direct tubular epithelial cell toxicity and alterations in renal haemodynamics with renal medullary ischaemia. Although the mediators of these changes are still not very clearly defined, alterations in the metabolism of prostaglandins, nitric oxide, endothelin, and adenosine may play a role.
Various preventive strategies have been employed to reduce the incidence of CN. These include administration of intravenous fluids [3, 4] , frusemide [5] , mannitol [5, 6] , low-dose dopamine [7] [8] [9] , atrial natriuretic peptide (ANP) [10] , and calcium-channel blockers [11, 12] . However, the results of most studies are conflicting, and more evidence is required before any therapeutic measures are recommended for routine use.
Since adenosine may have a role in the pathogenesis of CN, an adenosine antagonist (theophylline) has been investigated as a means of reducing the risk of CN [9, [13] [14] [15] . However, data on use of oral theophylline for this purpose is scant and inconsistent. The purpose of this prospective study was to determine whether alterations in renal function after administration of radiocontrast agents can be prevented by oral theophylline.
Materials and methods
We prospectively studied 70 consecutive patients of diabetes mellitus, aged 18-70 years, who were referred to our Institute for coronary angiography and had a serum creatinine -3.0 mgudl. A written informed consent was obtained from each patient prior to inclusion in the study and the study protocol conformed to the ethical guidelines of the Institute's Human Research Committee. Exclusion criteria included (i) pre-existing renal failure with serum creatinine 03.0 mgudl, (ii) maintenance dialysis, (iii) a history of acute myocardial infarction, (iv) left ventricular ejection fraction (EF) -25%, (v) allergy to contrast media, (vi) pregnancy, and (vii) diuretic therapy.
Prior to angiography, all patients had tests to measure serum Na q , K q , blood urea nitrogen (BUN), creatinine, and osmolality. A baseline assessment of urine Na q , K q , urea, creatinine, and osmolality was also done. Glomerular filtration rate (GFR) was calculated using the 99m Tc-DTPAclearance method. Two blood samples at 90 and 120 min were taken after 99m Tc-DTPA injections to measure GFR adjusted to the body surface area [16] .
The patients were randomized into two groups: group I (ns35), who underwent routine coronary angiography, and group II (ns35), who received oral theophylline 200 mg b.d. starting 24 h before the angiography and continuing for 48 h thereafter. In addition, all patients received intravenous normal saline (1 mlukguh) commencing 12 h before and continuing for 12 h after the procedure. Coronary angiography was performed using a high-osmolar contrast medium, diatrizoate meglumine (76% Urograffin; Schering AG, Berlin, Germany). All laboratory tests and renal scans were repeated 48 h after angiography.
Case definition
Clinically significant renal impairment was defined as a P25% rise in serum creatinine compared to a patient's baseline value [17] or a P25% fall in GFR, documented by renal scan.
Statistical analysis
Student's t-test and x 2 test were used to calculate the significance of the results. A P-value -0.05 was taken as significant. All data are expressed as means"SD. Regression analysis was performed for predictors of CN.
Results
There was no difference between the groups in terms of mean age at angiography (51.9"8.16 vs 54.52"9.16 years), mean left ventricular (LV) function (EF 56.6" 4.3 vs 57.8"3.9%), gender distribution (31 males, 4 females in group I, 33 males, 2 females in group II) and mean dose of contrast used (77.8"9.6 vs 80.2"8.6 ml of 76% Urograffin) ( Table 1) .
Prior to angiography the two groups had comparable serum creatinine (1.19"0.23 in group I vs 1.16"0.18 mgudl group II), BUN (13.95"2.61 vs 12.8"3.36 mgudl), urine creatinine (69.0"9.57 vs 70.1"14.04 mgudl) and urine urea levels (1.13"0.17 vs 1.27"0.48 mgudl). There were also no significant differences in serum Na q , K q , osmolality, serum uric acid, and urine Na q , K q or urine osmolality. Fractional excretion of sodium (Fe Na ) was also similar in both groups (1.38"0.31 vs 1.53"0.49, Ps0.27). The mean GFR as estimated by the plasma method was also not significantly different between the two groups (85.4"14.7 vs 86.8"15.8 mlumin) ( Table 1) .
Following angiography, there were no significant changes in serum creatinine concentrations (1.16"0.18 vs 1.24"0.21 mgudl) and BUN levels (12.8"3.36 vs 14.8"2.5 mgudl) in the theophylline group (group II). The mean GFR also did not change significantly in this group (86.8"15.8 vs 80.3"16.0 mlumin) compared with pre-angiographic values (Table 2 ). Fe Na levels increased significantly in the theophylline group after angiography from 1.53"0.49 to 1.69"0.53 (Ps0.02). There was no significant change in any of the other biochemical parameters following angiography in this group.
In contrast, patients who did not receive theophylline (group I) had a significant rise in serum creatinine (1.19"0.23 vs 1.44"0.32 mgudl, Ps0.03) after angiography ( Figure 1 ). This group also had a significant rise in BUN levels (13.95"2.6 vs 17.55"3.9 mgudl, Ps0.01) (Figure 2 ). There was a correspondingly significant fall in GFR following angiography (85.4"14.7 vs 66.8"14.8 mlumin, Ps0.008) (Figure 3 ). The mean percentage fall in GFR was 35.8% (Table 2) . Fe Na levels showed a significant rise following angiography (from 1.38"0.31 to 1.61"0.39, Ps0.006).
Incidence of CN
None of the patients in the theophylline group had more than a 25% rise in serum creatinine, but seven of 35 (20%) in the control group did (Ps0.017). Of those seven, five had an absolute increase in serum creatinine levels of P0.5 mg%. The more reliable GFR estimation revealed that CN developed in 11 of 35 patients (31%) in the placebo group (a P25% fall in GFR), while only one patient in the theophylline group showed a fall in GFR (Ps0.004). Interestingly, all seven patients who had a rise in serum creatinine following angiography also demonstrated a fall in GFR. In addition, four patients who did not have a rise in serum creatinine had a P25% fall in GFR. It was observed that the mean percentage fall in GFR in the seven patients who had a rise in serum creatinine was greater (38.6% fall) when compared with the four patients who had only a fall in GFR without a change in serum creatinine (their percentage fall in GFR being 31.1). Post-angiography, the mean serum creatinine was significantly higher in the placebo group (group I) as compared to those who received theophylline (group II) (1.44"0.3 vs 1.24"0.2 mgudl Ps0.03). The mean BUN (17.5"3.9 vs 14.8"2.5 mgudl, Ps 0.02) was also higher in group I patients. Post-angiography, GFR was significantly lower in group I as compared with group II (66.8"14.8 vs 80.2"16 mlumin, Ps0.008). Serum Na, K, osmolality, and urine biochemistry were not significantly different between the two groups.
We also compared patients who developed CN with those who did not. The mean age at angiography (55.7"10.4 vs 52.6"8.2 years), pre-angiography serum creatinine (1.18"0.2 vs 1.17"0.2 mgudl), BUN (15.4"1.9 vs 13.0"3.05 mgudl), mean GFR (85.8"7.9 vs 86"16.2 mlumin), and Fe Na (1.38"0.29 vs 1.48q 0.44) were not significantly different between them. Following angiography, as expected, the mean serum creatinine was significantly higher in these who developed CN (1.72"0.2 vs 1.27"0.23 mgudl, Ps0.001). The BUN was also slightly higher in these patients (19.43"3.99 vs 15.65"3.2 mgudl, Ps0.04). There were no significant differences in any other biochemical parameters. Post angiography GFR was significantly lower in those who developed CN (56.02"5.56 vs 76.57"15.96 mlumin, P-0.0001). Fe NA levels after angiography were slightly higher in those who developed CN (1.73"0.42 vs 1.64"0.47) but this difference did not reach statistical significance. None of the patients required dialysis. All patients had normalization of their serum creatinine by 72 h.
On univariate analysis, development of CN did not correlate significantly with any pre-angiographic biochemical variable, nor with the pre-angiographic GFR. There was a significant correlation with the mode of treatment (Ps0.006, r À0.422). On multivariate analysis, none of the pre-angiographic variables could predict development of CN. Fig. 1 . Post-angiographic change in serum creatinine in both groups. Fig. 2 . Post-angiographic change in BUN in both groups. 
Discussion
Intravenous administration of contrast continues to be an important and often preventable cause of hospital-acquired ARF. Although various definitions of CN appear in the literature, it is commonly defined as an acute decline in renal function after the administration of intravenous contrast agents, and in the absence of other causes. Patients with CN typically present with an acute rise in serum creatinine 24-48 h after the contrast study. Serum creatinine usually peaks at 3-5 days and usually returns to normal after 7-10 days. Almost all patients revert to normal renal function, and dialysis is rarely required. CN may result from a synergistic combination of direct tubular epithelial-cell toxicity and renal tubular ischaemia [17] . The nature of a contrast medium, the ions associated with it, and the ischaemia that results during a contrast study are critical determinants of the degree of cellular damage, while the osmolality of the solution is possibly only of secondary importance. The injection of contrast induces biphasic haemodynamic changes in the kidney, with a transient vasodilatation and an increase in renal blood flow followed by more prolonged vasoconstriction and decrease in the blood flow. Alterations in the renal renin-angiotensin system, prostaglandins, endothelin, nitric oxide, and adenosine have all been implicated in the pathogenesis of this phenomenon.
Whether or not clinically significant renal impairment occurs, depends on the risk profile of a patient. Risk factors include baseline renal impairment, diabetes mellitus, congestive heart failure, reduced effective arterial volume (e.g. dehydration), concomitant use of nephrotoxic drugs, and administration of high doses of contrast. Preventive strategies are vital, especially in high-risk patients.
Preventive strategies
Whilst only saline hydration has been shown to be effective in preventing CN, other preventive strategies have also been used to reduce the chance of developing CN. Saline hydration [3, 4] may correct any pre-existing dehydration, and may also counter the osmotic diuresis attributable to the contrast agent. However, there has been no randomized controlled trial to compare deliberate saline hydration to non-intervention. Although loop diuretics may reduce ischaemic damage by decreasing the oxygen demands of the medullary tubules, Solomon et al. [5] reported that CN was more common in patients given saline and frusemide than in those given saline alone, and current evidence is more against than in favour of frusemide in the prevention of CN. The role of mannitol is also controversial, with studies indicating that saline hydration alone is superior to its combination with mannitol infusion [5] . Weisberg et al. [6] reported that although mannitol increased the risk of CN in diabetic patients with renal insufficiency, it reduced the risk in non-diabetic azotaemic patients. Dopamine, acting via dopaminergic receptors, causes an increase in renal blood flow and inhibits Na q uH q transport in proximal renal tubules. Low-dose dopamine (3 mgukgumin) has been used, with some studies reporting benefit [7, 8] while others report no additional benefit over saline hydration [9] . In a previous study, we showed the significant benefit of lowdose dopamine in preventing CN in diabetic patients undergoing coronary angiography [7] . Studies with ANP [10] and calcium-channel blockers [11, 12] have also yielded conflicting results.
Role of non-ionic or low-osmolar contrast media (LOCM)
These contrast media, with one-half to one-third the osmolality of standard high-osmolar contrast media (HOCM), were developed in an attempt to reduce the incidence of CN. However, the risk of CN is not totally eliminated by the use of LOCM, although it is reduced when compared with the use of HOCM. Based on accumulated evidence and the high cost of these agents, it is prudent to use LOCM for patients with pre-existing renal impairment to minimize the risk of CN. It is perhaps unnecessary to use LOCM in a patient with normal renal function who is at a low risk of developing CN after angiography [17] . We used only HOCM in the diabetic patients in our study and observed that CN developed in 31% of patients in the placebo arm.
Role of adenosine
Adenosine has been shown to reduce renal blood flow and glomerular perfusion pressure by means of A1-receptor-mediated renal afferent arteriolar vasoconstriction and A2-receptor-mediated efferent arteriolar vasodilatation. The administration of contrast in human subjects is known to be associated with the production of endogenous intrarenal adenosine. The vasoconstrictive and potentially deleterious effects of adenosine on renal blood flow can be significantly reduced with adenosine antagonists (e.g. theophylline) and potentiated by dipyridamole, an inhibitor of adenosine re-uptake. Erley et al. [13] studied the role of intravenous theophylline (5 mgukg) and found that, compared with placebo, it prevented the fall in creatinine, inulin, and para-aminohippurate clearances. However, in their cohort, which included only 15% of diabetics, there were no significant changes in renal function in any of the patients they studied. In a study comparing saline hydration, saline hydration plus dopamine, and saline hydration plus intravenous aminophylline infusion, Abizaid et al. [9] reported that neither dopamine nor aminophylline reduced the incidence of CN when compared with saline hydration alone. Data for oral theophylline in the prevention of CN is scant and contradictory. Katholi et al. [14] studied the effect of 2.88 mgukg oral theophylline (every 12 h, four doses) compared with placebo in the prevention of CN. They reported that although serum creatinine did not change significantly, theophylline completely prevented the fall in creatinine clearance seen within 24 h after non-ionic contrast and reduced that seen after ionic contrast by about half. Another study, however, using 810 mg oral theophylline, indicated that it did not offer any benefit over routine saline hydration for the prevention of CN in patients with serum creatinine P1.5 mgudl receiving contrast media [18] .
We chose to include only diabetics in our patient population (compared with previous studies in which only 15-20% of the subjects were diabetics), as they are more prone to develop CN, and we expected that any possible benefit of the drug would be highlighted. There is data suggesting that most of the increased risk in diabetics is related to underlying chronic renal insufficiency rather than the presence of diabetes mellitus per se [18] . However, other studies have reported diabetes (especially the insulin-dependent type) to be an independent risk factor for the development of CN [19, 20] .
In our patient population, the two groups (group I, who received saline hydration only, and group II, who received saline hydration plus oral theophylline) were comparable in terms of mean age, gender, LV function, and mean dose of contrast used. There were no significant differences among them in terms of preangiographic serum creatinine (1.19"0.23 vs 1.16" 0.18 mgudl), BUN (13.95"2.61 vs 12.8"3.6 mgudl), urine creatinine (69.0"9.57 vs 70.1"14.04 mgudl), urine urea levels (1.13"0.17 vs 1.27"0.48 mgudl) and mean GFR (85.4"14.7 vs 86.8"15.8 mlumin). There was also no significant difference with respect to serum NauK, osmolality, serum uric acid, and urine NauK or osmolality.
Although no patient in the theophylline group demonstrated a rise in serum creatinine P25% following angiography, such a rise was seen in seven of 35 (20%) in the control group. Estimation of GFR demonstrated that only one of 35 (2%) in the theophylline group had a )25% reduction in GFR, while CN occurred in 11 of 35 patients in the placebo arm (31%). Interestingly, all seven patients in the control group who had a rise in serum creatinine also had a fall in GFR. In addition, three patients (in the control group) and one patient (in the theophylline group) also had a measurable reduction in GFR despite no significant change in serum creatinine levels.
Post-angiography, the mean serum creatinine was significantly higher in the control group (1.44"0.32 vs 1.24"0.21 mgudl, Ps0.03). Patients who did not receive theophylline also had higher BUN (17.55" 3.9 vs 14.8"2.5 mgudl, Ps0.02) and significantly lower GFR following angiography (66.8"14.8 vs 80.2"16 mlumin, Ps0.02). The other biochemical parameters were not significantly different between these two groups. Overall, the renal dysfunction in our study was mild and no patient required dialysis. This could be because we excluded diabetic patients with moderate to severe renal failure (serum creatinine P3 mgudl). It could also be due to the use of saline hydration even in the control group.
None of the pre-angiographic variables predicted development of CN. The fact that no pre-angiographic biochemical or demographic parameter can predict accurately which patient will develop CN highlights the need to develop adequate prophylactic preventative measures. We found oral theophylline (an adenosine antagonist) to be safe and effective for the prevention of CN in diabetic patients undergoing coronary angiography with ionic contrast media.
